HYPERVITAMINOSIS B12 – IS IT A SIGNIFICANT PARAMETER IN THE CONTEXT OF CANCER? – REVIEW PAPER

Keywords: Vitamin B12, Hypervitaminosis B12, Cancer, Colorectal Cancer, Solid Tumor

Abstract

Introduction and Objective
Vitamin B12 plays an important role in hematopoiesis, the synthesis of myelin sheaths and the DNA methylation process. Food products rich in vitamin B12 include meat, offal, eggs, fish, and fermented plants. Hypervitaminosis B12 is serum level of this vitamin exceeding the reference range. Causes of this condition include liver or kidney failure, autoimmune diseases, infections, excessive supplementation, improper diet and malignant neoplasms.

Materials and Methods
The aim of our paper is analyzing studies about relationship between hypervitaminosis B12 and cancer disease. All articles are available in Google Scholar database in English, full-text online and free of charge. The phrase used for the search was ‘Vitamin B12 cancer’.

Results
Conclusions drawn by analyzed studies. Oncologic patients exhibit higher average levels of vitamin B12. Hypervitaminosis B12 adversely impacts survival time in patients with diagnosed cancer. Prolonged hypervitaminosis is more frequently associated with the future occurrence of malignant neoplasms compared to temporarily elevated levels. During cancer regression, vitamin B12 levels normalize. Increased mortality among patients with hypervitaminosis B12 is observed both in oncologic and internal medicine patients.

Conclusions
The diagnosis of hypervitaminosis B12 should not be marginalized. Detailed diagnostics should be implemented to find its cause. In the future, monitoring the level of vitamin B12 may prove helpful in cancer prevention and in assessing the effectiveness of anticancer treatment. The detailed connections between vitamin B12 and the occurrence of malignant tumors are still unclear and require further scientific research.

References

Smith E. L. (1950). Isolation and chemistry of vitamin B12. Proceedings of the Royal Society of Medicine, 43(7), 535–536. https://doi.org/10.1177/003591575004300707

Romain, M., Sviri, S., Linton, D. M., Stav, I., & van Heerden, P. V. (2016). The role of Vitamin B12 in the critically ill--a review. Anaesthesia and intensive care, 44(4), 447–452. https://doi.org/10.1177/0310057X1604400410

Starostka-Tatar, A., & Łabuz-Roszak, B. (2023). Vitamin B12 deficiency in clinical practice. Lekarz POZ, 9(5), 279-282.

Karapiperi, K., Gousis, C., & Papaioannidou, P. (2010). The role of vitamin B12 in DNA modulation mechanisms. Front. Pharmacol. Conference Abstract: 8th Southeast European Congress on Xenobiotic Metabolism and Toxicity - XEMET 2010. https://doi.org/10.3389/conf.fphar.2010.60.00140

EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). (2015). Scientific Opinion on Dietary Reference Values for cobalamin (vitamin B12). EFSA Journal 2015; 13(7):4150, 64 pp. https://doi.org/10.2903/j.efsa.2015.4150

Kyriazi, V. (2024). B12 Hypervitaminemia: Pathogenetic Pathways and Clinical Implications. International Journal of Caring Sciences, 17(2), 1178- 1189

Haghighat, G., Khajeh-Mehrizi, A., & Ranjbar, H. (2023). Evaluation of Serum Vitamin B12 Levels in Patients with Colon and Breast Cancer: A Case-Control Study. International journal of hematology-oncology and stem cell research, 17(4), 240–244. https://doi.org/10.18502/ijhoscr.v17i4.13914

Sun, N. H., Huang, X. Z., Wang, S. B., Li, Y., Wang, L. Y., Wang, H. C., Zhang, C. W., Zhang, C., Liu, H. P., & Wang, Z. N. (2016). A dose-response meta-analysis reveals an association between vitamin B12 and colorectal cancer risk. Public health nutrition, 19(8), 1446–1456. https://doi.org/10.1017/S136898001500261X

Boughanem, H., Hernandez-Alonso, P., Tinahones, A., Babio, N., Salas-Salvadó, J., Tinahones, F. J., & Macias-Gonzalez, M. (2020). Association between Serum Vitamin B12 and Global DNA Methylation in Colorectal Cancer Patients. Nutrients, 12(11), 3567. https://doi.org/10.3390/nu12113567

Oh, H. K., Lee, J. Y., Eo, W. K., Yoon, S. W., & Han, S. N. (2017). Elevated Serum Vitamin B12 Levels as a Prognostic Factor for Survival Time in Metastatic Cancer Patients: A Retrospective Study. Nutrition and Cancer, 70(1), 37–44. https://doi.org/10.1080/01635581.2018.1397711

Lacombe, V., Chabrun, F., Lacout, C., Ghali, A., Capitain, O., Patsouris, A., Lavigne, C., & Urbanski, G. (2021). Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer. Scientific reports, 11(1), 13361. https://doi.org/10.1038/s41598-021-92945-y

Molina-Pimienta, L., Amado-Garzón, S. B., Salgado-Sánchez, J. C., & Vásquez-Jiménez, J. M. (2023). Elevated B12 levels and mortality among inpatients at a university hospital in Colombia. Revista de la Facultad de Medicina, 71(4), 105619. https://doi.org/10.15446/revfacmed.v71n4.105619

Çavuşoğlu B., Solmaz K., Türker F., & Ataoğlu E. (2024) An Independent Predictor of Mortality in Hospitalized Patients: Vitamin B12. DAHUDER Medical Journal, 4 (3), 64–70. https://doi.org/10.56016/dahudermj.1494846

Views:

16

Downloads:

16

Published
2025-06-09
Citations
How to Cite
Emilia Majewska, Izabela Domańska, Aleksandra Sagan, Monika Domagała, Joanna Wiewióra, Weronika Duda, & Małgorzata Piśkiewicz. (2025). HYPERVITAMINOSIS B12 – IS IT A SIGNIFICANT PARAMETER IN THE CONTEXT OF CANCER? – REVIEW PAPER. International Journal of Innovative Technologies in Social Science, (2(46). https://doi.org/10.31435/ijitss.2(46).2025.3310

Most read articles by the same author(s)